The Fe 2+ ‐Mediated Decomposition, PfATP6 Binding, and Antimalarial Activities of Artemisone and Other Artemisinins: The Unlikelihood of C‐Centered Radicals as Bioactive Intermediates
Open accessThe DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Abstract
The results of Fe 2+ ‐induced decomposition of the clinically used artemisinins, artemisone, other aminoartemisinins, 10‐deoxoartemisinin, and the 4‐fluorophenyl derivative have been compared with their antimalarial activities and their ability to inhibit the parasite SERCA PfATP6. The clinical artemisinins and artemisone decompose under aqueous conditions to give mixtures of C radical marker products, carbonyl compounds, and reduction products. The 4‐fluorophenyl derivative and aminoartemisinins tend to be inert to aqueous iron(II) sulfate and anhydrous iron(II) acetate. Anhydrous iron(II) bromide enhances formation of the carbonyl compounds and provides a deoxyglycal from DHA and enamines from the aminoartemisinins. Ascorbic acid (AA) accelerates the aqueous Fe 2+ ‐mediated decompositions, but does not alter product distribution. 4‐Oxo‐TEMPO intercepts C radicals from a mixture of an antimalaria‐active trioxolane, 10‐deoxoartemisinin, and anhydrous iron(II) acetate to give trapped products in 73 % yield from the trioxolane, and 3 % from the artemisinin. Artemisone provides a trapped product in 10 % yield. Thus, in line with its structural rigidity, only the trioxolane provides a C radical eminently suited for intermolecular trapping. In contrast, the structural flexibility of the C radicals from the artemisinins allows facile extrusion of Fe 2+ and collapse to benign isomerization products. The propensity towards the formation of radical marker products and intermolecular radical trapping have no relationship with the in vitro antimalarial activities of the artemisinins and trioxolane. Desferrioxamine (DFO) attenuates inhibition of PfATP6 by, and antagonizes antimalarial activity of, the aqueous Fe 2+ ‐susceptible artemisinins, but has no overt effect on the aqueous Fe 2+ ‐inert artemisinins. It is concluded that the C radicals cannot be responsible for antimalarial activity and that the Fe 2+ ‐susceptible artemisinins may be competitively decomposed in aqueous extra‐ and intracellular compartments by labile Fe 2+ , resulting in some attenuation of their antimalarial activities. Interpretations of the roles of DFO and AA in modulating antimalarial activities of the artemisinins, and a comparison with antimalarial properties of simple hydroperoxides and their behavior towards thapsigargin‐sensitive SERCA ATPases are presented. The general basis for the exceptional antimalarial activities of artemisinins in relation to the intrinsic activity of the peroxide within the uniquely stressed environment of the malaria parasite is thereby adumbrated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“iron-catalysed radical formation is also significantly involved in the antimalarial (i.e. cytotoxic) mode of action of artemisinin [1494,1496-1504], and this reaction is in fact inhibited by iron chelators [1505] such that a combined artemisinin-chelator therapy would be contraindicated.”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1502]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andrews, S. C., Robinson, A. K., & Rodríguez-Quiñones, F. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00055-x · Cited by 2,702
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S.-S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2004 · Cited by 2,575
Qinghaosu (Artemisinin): an Antimalarial Drug from China
Klayman, D. L. (1985) · Science · doi:10.1126/science.3887571 · Cited by 2,186
Water: From Clusters to the Bulk
Ludwig, R. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20010518)40:10<1945::aid-anie1945>3.0.co;2-5 · Cited by 1,300
White, N. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421682 · Cited by 1,248
Artemisinins target the SERCA of Plasmodium falciparum
Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., O'Neill, P. M., Bray, P. G., Ward, S. A., & Krishna, S. (2003) · Nature · doi:10.1038/nature01813 · Cited by 1,027
Self-citationIron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site.
Graf, E., Mahoney, J. R., Bryant, R. G., & Eaton, J. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43139-5 · Cited by 855
Kakhlon, O., & Cabantchik, Z. I. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01006-7 · Cited by 839
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Chemical aspects of siderophore mediated iron transport
Boukhalfa, H., & Crumbliss, A. L. (2002) · Biometals · doi:10.1023/a:1020218608266 · Cited by 547
Research works printed but not linked: 23
- Liu J.‐M., 1979, Acta Chim. Sin., 37, 129
- Li Y., 1979, Ke Xue Tong Bao, 24, 667
- Liu X., 1980, Yao Xue Tong Bao, 15, 183
- Li Y., 1981, Acta Pharm. Sin., 16, 429
- Li Y., 1982, Acta Chim. Sin., 40, 557
- Li L., 1986, Jiegou Huaxue, 5, 73
- 10.1172/jci21682 · doi:10.1172/jci21682 · Paper page
- Jiang J.‐B., 1982, Lancet, 2, 8293
- Li G.‐Q., 1984, Lancet, 2, 8416
- Olliaro P. L., 2004, J. Postgrad. Med., 50, 40
- Kremsner P. G., 2004, Lancet, 363, 284
- T. N. Trung D. V. Phuc “Comparison of Artequick Tablets and Granules in Treatment of Complicated Falciparum Malaria in Vietnam” Second International Artemisinin Compounds Workshop on the Evaluation of Clinical Studies January 16–17 2007 Guangzhou China.
- 10.1002/(sici)1521-3773(19990903)38:17<2580::aid-anie2580>3.0.co;2-j · doi:10.1002/(sici)1521-3773(19990903)38:17<2580::aid-anie2580>3.0.co;2-j
- Grace J. M., 1998, Drug Metab. Dispos., 26, 313
- 10.1002/1521-3773(20010518)40:10<1954::aid-anie1954>3.0.co;2-9 · doi:10.1002/1521-3773(20010518)40:10<1954::aid-anie1954>3.0.co;2-9
- 10.1016/s0140-6736(05)67787-2 · doi:10.1016/s0140-6736(05)67787-2
- 10.1021/jo050385 · doi:10.1021/jo050385
- Meshnick S. R., 1989, Prog. Clin. Biol. Res., 313, 95
- 10.1007/3-540-29088-5_12 · DOI
- Clark I. A., 1984, Clin. Exp. Immunol.., 56, 524
- Lu C.‐H., 2002, Chin. J. Physiol., 45, 51
- Lopez‐Shirley K., 1994, J. Lab. Clin. Med., 123, 126
- 10.1016/j.vph.2004.11.001 · DOI
Cited by
Qinghaosu (Artemisinin): The Price of Success
White, N. J. (2008) · Science · doi:10.1126/science.1155165 · Cited by 954
The Molecular Mechanism of Action of Artemisinin—The Debate Continues
O’Neill, P. M., Barton, V. E., & Ward, S. A. (2010) · Molecules · doi:10.3390/molecules15031705 · Cited by 595
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Artemisinins: their growing importance in medicine
Krishna, S., Bustamante, L., Haynes, R. K., & Staines, H. M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.07.004 · Cited by 388
Self-citationDiscovery, mechanisms of action and combination therapy of artemisinin
Cui, L., & Su, X.-Z. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.68 · Cited by 371
Metadata
- Authors
- Haynes, R. K., Chan, W. C., Lung, C., Uhlemann, A., Eckstein, U., Taramelli, D., Parapini, S., Monti, D., & Krishna, S.
- Affiliations
- Hong Kong University of Science and Technology (HK)
- University of London (GB)
- University of Milan (IT)
- Institute of Molecular Science and Technologies (IT)
- St George's Hospital (GB)
- ORCID
- Venue
- ChemMedChem
- Publisher
- Wiley
- Published
- 2007-09-26
- Volume
- 2
- Issue
- 10
- Pages
- 1480-1497
- ISSN
- 1860-7179 (ISSN-L)
- 1860-7187
- OpenAlex
- W2000312340
- Cited by
- 123
- References
- 127
- Citations by year
- 2026: 4 · 2024: 3 · 2023: 7 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 4 · 2015: 4 · 2014: 4 · 2013: 7 · 2012: 6
- FWCI
- 13.44
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- ChemMedChem (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Physical Sciences › Chemistry › Organic Chemistry › Sesquiterpenes and Asteraceae Studies
- Physical Sciences › Chemistry › Organic Chemistry › Physical Organic Chemistry and Reaction Kinetics
- Keywords
- artemisone, carbon-centered radicals, radical trapping, tempo, antimalarial activity, PfATP6, SERCA inhibition, deferoxamine, carbonyl compounds
- MeSH terms
- Calcium-Transporting ATPases, Animals, Antimalarials, Deferoxamine, Ferrous Compounds, Kinetics, Plasmodium falciparum, Likelihood Functions, Artemisinins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Fe 2+ ‐Mediated Decomposition, PfATP6 Binding, and Antimalarial Activities of Artemisone and Other Artemisinins: The Unlikelihood of C‐Centered Radicals as Bioactive Intermediates. https://app.cochat.ai/papers/10.1002/cmdc.200700108
- The paper
- Haynes, R. K., Chan, W. C., Lung, C., Uhlemann, A., Eckstein, U., Taramelli, D., Parapini, S., Monti, D., & Krishna, S. (2007). The Fe 2+ ‐Mediated Decomposition, PfATP6 Binding, and Antimalarial Activities of Artemisone and Other Artemisinins: The Unlikelihood of C‐Centered Radicals as Bioactive Intermediates. ChemMedChem. https://doi.org/10.1002/cmdc.200700108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.